<DOC>
	<DOCNO>NCT02750319</DOCNO>
	<brief_summary>This trial compare combination amiodarone NAC ( n=122 ) amiodarone alone NAC match placebo ( n=122 ) determine rate sustain ( last &gt; 30 second ) clinically significant POAF reduce high risk patient within 7 day major thoracic surgery .</brief_summary>
	<brief_title>Amiodarone N-Acetylcysteine Amiodarone Alone Preventing Atrial Fibrillation After Thoracic Surgery</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Amiodarone</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>Patients ≥18 year old schedule elective thoracic surgery ( segmentectomy , lobectomy bilobectomy , pneumonectomy esophagectomy ) meet one four follow risk criterion : 1 . Female &amp; BNP ≥ 25pg/ml ( age limit ) 2 . Male gender &lt; 75 &amp; BNP ≥ 25pg/ml 3 . Male age ≥75 ( No BNP limit ) 4 . History prior AF Patients sinus rhythm . Patients stable respiratory status ( respiratory distress ) . Patients capable provide write , informed consent . Patients scheduled extrapleural pneumonectomy . Hemodynamically unstable patient ( cardiogenic shock acute MI ) . Patients 2nd 3rd degree atrioventricular ( AV ) block . Patients hypersensitivity amiodarone NAC . Patients already take class Ic III antiarrhythmic drug . Hepatic insufficiency ( &gt; 1.5 time upper normal limit transaminase level ) . Renal insufficiency ( creatinine ≥2.0 mg/dl ) . Known pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Amiodarone</keyword>
	<keyword>N-Acetylcysteine</keyword>
	<keyword>16-307</keyword>
</DOC>